Clinical outcome of autologous peripheral blood stem cell transplantation in opticospinal and conventional forms of secondary progressive multiple sclerosis in a Chinese population

Annals of Hematology

Volumn 90, Issue 3, 2011, Pages 343-348

  Xu, Juan ^a   Ji, Bing Xin ^a   Su, Li ^a   Dong, Hui Qing ^a   Sun, Wan Ling ^a   Wan, Sui Gui ^a   Liu, Ya Ou ^a   Zhang, Pu ^a   Liu, Cong Yan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Autologous peripheral blood stem cell transplantation; Chinese; Clinical outcome; Opticospinal multiple sclerosis

Indexed keywords

CARMUSTINE; CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TENIPOSIDE;

ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CHINESE; CLINICAL ARTICLE; DETERIORATION; DIARRHEA; EVENT FREE SURVIVAL; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HUMAN; LEUKAPHERESIS; MALE; MULTIPLE SCLEROSIS; OPTIC NEURITIS; OPTICOSPINAL MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENCE RISK; RELAPSE; STEM CELL MOBILIZATION; SURVIVAL RATE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARMUSTINE; CHINA; CYTARABINE; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; MALE; MELPHALAN; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; NEUROMYELITIS OPTICA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECURRENCE; REMISSION INDUCTION; SPINAL CORD; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79951683336     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-1071-5     Document Type: Article

References (26)

1. A Compston A Coles 2008 Multiple sclerosis Lancet 372 1502 1517 1:CAS:528:DC%2BD1cXht12gtLvN 10.1016/S0140-6736(08)61620-7 18970977
2. WL McDonald A Compston G Edan, et al. 2001 Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis Ann Neurol 50 121 127 1:STN:280: DC%2BD38%2FitFOhug%3D%3D 10.1002/ana.1032 11456302 (Pubitemid 32591472)
3. J Kira 2003 Multiple sclerosis in the Japanese population Lancet Neurol 2 117 127 10.1016/S1474-4422(03)00308-9 12849268 (Pubitemid 37443332)
4. M Wasay IA Khatri B Khealani, et al. 2006 MS in Asian countries Int MS J 13 58 65 1:STN:280:DC%2BD283mvVGnsQ%3D%3D 16696904 (Pubitemid 43764529)
5. CF Lucchinetti RN Mandler D McGavern, et al. 2002 A role for humoral mechanisms in the pathogenesis of Devic's nueromyelitis optica Brain 125 1450 1461 10.1093/brain/awf151 12076996 (Pubitemid 34755161)
6. BG Weinshenker DM Wingerchuk I Nakashima, et al. 2006 OSMS is NMO, but not MS: proven clinically and pathologically Lancet Neurol 5 110 111 10.1016/S1474-4422(06)70333-7 16426985 (Pubitemid 43107844)
7. S Kikuchi T Fukazawa 2005 "OSMS is NMO, but not MS": confirmed by NMO-IgG? Lancet Neurol 4 594 595 10.1016/S1474-4422(05)70179-4 16168927 (Pubitemid 41317293)
8. DM Wingerchuk SJ Pittock CF Lucchinetti, et al. 2007 A secondary progressive clinical course is uncommon in neuromyelitis optical Neurology 68 603 605 1:STN:280:DC%2BD2s7htVGgtg%3D%3D 10.1212/01.wnl.0000254502.87233.9a 17310032
9. I Nakashima K Fujihara I Miyazawa, et al. 2006 Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG J Neurol Neurosurg Psychiatry 77 1073 1075 1:STN:280:DC%2BD28vptVKlsA%3D%3D 10.1136/jnnp.2005.080390 16505005 (Pubitemid 44338534)
10. T Matsuoka T Matsushita Y Kawano, et al. 2007 Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese Brain 130 1206 1223 10.1093/brain/awm027 17439988 (Pubitemid 47355945)
11. J Kira 2008 Neuromyelitis optica and Asian phenotype of multiple sclerosis Ann N Y Acad Sci 1142 58 71 1:CAS:528:DC%2BD1cXhsV2hsb7M 10.1196/annals.1444.002 18990121
12. M Matsui 2008 Classification of MS and treatment strategy Nippon Rinsho 66 1112 1116 18540356
13. M Keegan AA Pineda RL McClelland CH Darby, et al. 2002 Plasma exchange for severe attacks of CNS demyelination: predictors of response Neurology 58 143 146 1:STN:280:DC%2BD38%2FlsF2rsg%3D%3D 11781423
14. DM Wingerchuk BG Weinshenker 2005 Neuromyelitis Optica Curr Treat Options Neurol 7 173 182 10.1007/s11940-005-0010-6 15814070 (Pubitemid 40894929)
15. G Comi L Kappos M Clanet, et al. 2000 Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European group for blood and marrow transplantation and the European Charcot foundation J Neurol 247 376 382 1:STN:280: DC%2BD3cvps1GgtQ%3D%3D 10.1007/s004150050605 10896270 (Pubitemid 30364617)
16. R Saccardi T Kozak C Bocelli-Tyndall, et al. 2006 Autologous stem cell transplantation for progressive multiple sclerosis: update of the European group for blood and marrow transplantation autoimmune disease working party database Mutl Scler 12 814 823 1:STN:280:DC%2BD2s%2FlvVyktg%3D%3D 10.1177/ 1352458506071301 (Pubitemid 46111776)
17. J Kira T Kanai Y Nishimura, et al. 1996 Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders Ann Neurol 40 569 574 1:STN:280:DyaK2s%2FisFertw%3D%3D 10.1002/ana.410400405 8871575 (Pubitemid 26357880)
18. DW Beelen R Peceny A Elmaagacli, et al. 2000 Transplantation of highly purified HLA-identical sibling donor peripheral blood CD34+ cells without prophylactic post-transplant immunosuppression in adult patients with first chronic phase chronic myeloid leukemia: results of a phase II study Bone Marrow Transplant 26 823 829 1:STN:280:DC%2BD3M7itV2jtw%3D%3D 10.1038/sj.bmt.1702635 11081380
19. A Fassas A Anagnostopoulos A Kazis, et al. 2000 Autologous stem cell transplantation in progressive multiple sclerosis-an interim analysis of efficacy J Clin Immunol 20 24 30 1:STN:280:DC%2BD3c3ls1ClsA%3D%3D 10.1023/A:1006686426090 10798604 (Pubitemid 30210103)
20. JF Kurtzke 1983 Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1444 1452 1:STN:280:DyaL2c%2FktValsQ%3D%3D 6685237 (Pubitemid 14237132)
21. D Graber M Levy D Kerr, et al. 2008 Neuromyelitis optica pathogenesis and aquaporin 4 J Neuroinflammation 5 22 42 10.1186/1742-2094-5-22 18510734 (Pubitemid 351858929)
22. S Nielsen EA Nagelhus M Amiry-Moghaddam, et al. 1997 Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain J Neurosci 17 171 180 1:CAS:528:DyaK2sXms1Sn 8987746 (Pubitemid 27008860)
23. SF Roemer JE Pa risi VA Lennon, et al. 2007 Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis Brain 130 1194 1205 10.1093/brain/awl371 17282996 (Pubitemid 47355941)
24. T Ishizu M Osoegawa FJ Mei, et al. 2005 Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis Brain 128 988 1002 10.1093/brain/awh453 15743872 (Pubitemid 40675455)
25. A Jacob BG Weinshenker I Violich, et al. 2008 Treatment of neuromyelitis optica with Rituximab Arch Neurol 65 1443 1448 10.1001/archneur.65.11.noc80069 18779415
26. K Hawker P O'Connor MS Freedman, et al. 2009 Rituximab in patients with primary progressive multiple sclerosis. Results of a randomized double-blind placebo-controlled multicenter trial Ann Neurol 66 460 471 1:CAS:528: DC%2BD1MXhsVehtr3N 10.1002/ana.21867 19847908